{"id":54220,"date":"2023-02-24T12:04:16","date_gmt":"2023-02-24T11:04:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/"},"modified":"2023-02-24T12:04:16","modified_gmt":"2023-02-24T11:04:16","slug":"aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/","title":{"rendered":"Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference"},"content":{"rendered":"<div>\n<p>VICTORIA, British Columbia&#8211;(BUSINESS WIRE)&#8211;Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Peter Greenleaf, President and Chief Executive Officer, will give a corporate presentation at the upcoming investor healthcare conference.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230224005026\/en\/1721835\/4\/aurina_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230224005026\/en\/1721835\/21\/aurina_logo.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nOppenheimer 33rd Annual Virtual Healthcare Conference being held March 13 \u2013 15, 2023. Presentation time Tuesday, March 14, from 9:20 \u2013 9:50 AM ET.\n<\/li>\n<\/ul>\n<p>\nTo participate in the audio webcast, interested parties can access the live webcast under &#8220;News\/Events\u201d through the \u201cInvestors\u201d section of the Aurinia corporate website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.auriniapharma.com%2F&amp;esheet=53342637&amp;newsitemid=20230224005026&amp;lan=en-US&amp;anchor=www.auriniapharma.com&amp;index=1&amp;md5=90443fe05a528337b0c19b18b6fde918\" rel=\"nofollow noopener\" shape=\"rect\">www.auriniapharma.com<\/a>.\n<\/p>\n<p>\n<b>About Aurinia<\/b>\n<\/p>\n<p>\nAurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by autoimmune, kidney and rare diseases with a high unmet medical need. In January 2021, the Company introduced LUPKYNIS<sup>\u00ae<\/sup> (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis (LN). The Company\u2019s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor\/Media Contact:<\/b><br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x41;&#x75;&#x72;&#x69;&#x6e;&#x69;&#x61;&#x40;&#x77;&#x65;&#x73;&#x74;&#x77;&#x69;&#x63;&#x6b;&#x65;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x41;&#x75;&#x72;&#x69;&#110;&#105;&#97;&#64;wes&#x74;&#x77;&#x69;&#x63;&#x6b;&#101;&#46;&#99;om<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>VICTORIA, British Columbia&#8211;(BUSINESS WIRE)&#8211;Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Peter Greenleaf, President and Chief Executive Officer, will give a corporate presentation at the upcoming investor healthcare conference. Oppenheimer 33rd Annual Virtual Healthcare Conference being held March 13 \u2013 15, 2023. Presentation time Tuesday, March 14, from 9:20 \u2013 9:50 &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54220","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"VICTORIA, British Columbia&#8211;(BUSINESS WIRE)&#8211;Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Peter Greenleaf, President and Chief Executive Officer, will give a corporate presentation at the upcoming investor healthcare conference. Oppenheimer 33rd Annual Virtual Healthcare Conference being held March 13 \u2013 15, 2023. Presentation time Tuesday, March 14, from 9:20 \u2013 9:50 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-24T11:04:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230224005026\/en\/1721835\/21\/aurina_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference\",\"datePublished\":\"2023-02-24T11:04:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/\"},\"wordCount\":180,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005026\\\/en\\\/1721835\\\/21\\\/aurina_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/\",\"name\":\"Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005026\\\/en\\\/1721835\\\/21\\\/aurina_logo.jpg\",\"datePublished\":\"2023-02-24T11:04:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005026\\\/en\\\/1721835\\\/21\\\/aurina_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230224005026\\\/en\\\/1721835\\\/21\\\/aurina_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference - Pharma Trend","og_description":"VICTORIA, British Columbia&#8211;(BUSINESS WIRE)&#8211;Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Peter Greenleaf, President and Chief Executive Officer, will give a corporate presentation at the upcoming investor healthcare conference. Oppenheimer 33rd Annual Virtual Healthcare Conference being held March 13 \u2013 15, 2023. Presentation time Tuesday, March 14, from 9:20 \u2013 9:50 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-24T11:04:16+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230224005026\/en\/1721835\/21\/aurina_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference","datePublished":"2023-02-24T11:04:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/"},"wordCount":180,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230224005026\/en\/1721835\/21\/aurina_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/","name":"Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230224005026\/en\/1721835\/21\/aurina_logo.jpg","datePublished":"2023-02-24T11:04:16+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230224005026\/en\/1721835\/21\/aurina_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230224005026\/en\/1721835\/21\/aurina_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-present-at-upcoming-investor-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Aurinia Pharmaceuticals to Present at Upcoming Investor Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54220","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54220"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54220\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}